SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report)’s stock price dropped 1.2% during trading on Tuesday . The company traded as low as $24.38 and last traded at $24.38. 200 shares changed hands during trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Stock Down 1.2%
The stock has a market cap of $6.64 billion, a P/E ratio of 48.76, a P/E/G ratio of 1.30 and a beta of 1.81. The company’s 50 day moving average price is $24.38 and its two-hundred day moving average price is $24.38.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB, known as Sobi, is a Sweden-based specialty pharmaceutical company focused on developing, manufacturing and commercializing medicines for rare diseases. The company’s primary therapeutic areas include hematology, immunology and other conditions with significant unmet medical needs.
Sobi’s portfolio includes treatments for inherited and acquired blood disorders, immune-mediated diseases and related specialty-care conditions. Its products and development programs are distributed across international markets, with commercial activities spanning Europe, North America and selected regions in the Middle East, Asia and other global markets.
The company traces its roots to Swedish pharmaceutical operations established in the 1930s and adopted its current name after Swedish Orphan International combined with Biovitrum in 2010.
See Also
- Five stocks we like better than SWEDISH ORPHAN/S
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
